Skip to main content
Clinical Trials/NCT07539701
NCT07539701Not yet recruitingNot Applicable

An Initial Experience With the Disposable Celsio Cryocatheter System for Diagnostic and Interventional Bronchoscopy

Institut universitaire de cardiologie et de pneumologie de Québec, University Laval1 site in 1 country30 target enrollmentStarted: March 23, 2026Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Not yet recruiting
Sponsor
Enrollment
30
Locations
1
Primary Endpoint
Procedural completion rate

Study Overview

Brief Summary

This clinical trial is intended for patients awaiting an interventional bronchoscopy procedure where the use of a cryocatheter is considered. This type of catheter is already used in clinical practice for the treatment of certain types of bronchial obstructions, including tumors, granulomas, and for foreign bodies extractions. This catheter uses extremely cold temperatures offering unique advantages compared to heat-based technologies. Different types of reusable and single-use cryocatheters are actually available on the market. This type of device requires the use of expensive and bulky consoles operating with heavy gas tanks, resulting in high maintenance costs. A Quebec, Canada based company has developed a cryocatheter that combines procedural efficacy with practical considerations in mind. The Celsio cryocatheter operates without a console and is designed to accommodate the bronchscopist through the different types of cryogenic procedures.

This study aims to generate meaningful, real-world evidence without interfering with standard clinical care. The collected data will serve to characterize the device's performance profile, identify best practices for its use, and provide data for the design of future prospective comparative studies.

Study Design

Study Type
Interventional
Allocation
Na
Intervention Model
Single Group
Primary Purpose
Diagnostic
Masking
None

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • - Patient undergoing a bronchoscopic procedure with planned use of a 1.7mm cryocatheter

Exclusion Criteria

  • Patient undergoing a bronchoscopic procedure with planned use of a different size cryocatheter (eg 1.1 or 2.4mm)
  • Current pregnancy or lactation
  • Lack of free and informed consent

Arms & Interventions

undergoing bronchoscopic procedures using the Celsio Cryocatheter Device

Experimental

Subject with a clinically required bronchoscopic intervention planned with the use of a cryocathter (cryobiopsy or cryo-extraction or cryo-devitalization) will undergo the procedure with the Celso cryocathter device

Intervention: Disposable Flexible Cryocatheter System (Device)

Outcomes

Primary Outcomes

Procedural completion rate

Time Frame: From first bronchoscope introduction into the patient (beginning of the procedure) to last bronchoscope removal (end of the procedure)

Procedural completion will be defined as the completion of all planned procedure steps involving the study device, without device technical dysfunction

Secondary Outcomes

  • Adverse events rate(During the procedure until 30 days post-intervention)
  • Diagnostic yield(From procedure to end of follow up at 2 years)
  • Procedural duration(From beginning of the procedure to end of the procedure)

Investigators

Sponsor
Institut universitaire de cardiologie et de pneumologie de Québec, University Laval
Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Marc Fortin

Respirologist, MD, MSc

Institut universitaire de cardiologie et de pneumologie de Québec, University Laval

Study Sites (1)

Loading locations...

Similar Trials